Clinical Trial Update: Venetoclax and CLAG-M for the Treatment of Acute Myeloid Leukemia and High-Grade Myeloid Neoplasms [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial evaluating venetoclax in combination with the CLAG-M chemotherapy regimen for acute myeloid leukemia and related high-grade mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Mixed Phenotype Acute Leukemia

Drugs mentioned

• CLAG-M regimen
• Venetoclax (venetoclax)

Snippet

Sponsor: University of Washington | Conditions: Acute Biphenotypic Leukemia, Acute Myeloid Leukemia | Phase 1, Phase 2 | Status: RECRUITING